DOI QR코드

DOI QR Code

The roles of endoscopic ultrasound in the diagnosis of pancreatobiliary cancer

췌·담도암 진단에 있어서 내시경초음파의 역할

  • Kim, Kook Hyun (Division of Gastroenterology and Hepatology, Department of Internal Medicine, College of Medicine, Yeungnam University)
  • 김국현 (영남대학교 의과대학 내과학교실)
  • Received : 2016.10.31
  • Accepted : 2016.11.18
  • Published : 2016.11.18

Abstract

Pancreatic cancer, the 4th leading cause of cancer-related death in the United States, has a very poor prognosis. Cholangiocarcinoma originates from either intrahepatic or extrahepatic bile duct, and its incidence is gradually increasing worldwide. Endoscopic retrograde cholangiopancreatography with brush cytology has a high false-negative rate for the diagnosis of biliary malignancy. Recently, endoscopic ultrasonography (EUS) has emerged as the potential modality to detect pancreatic cancer. EUS-guided fine needle aspiration for cytologic analysis made it possible to overcome the obstacle in differentiating between benign and malignant lesions in the pancreatobiliary lesion, and it has been well established as a safe and effective procedure. Herein, the clinical application of EUS in the diagnosis of pancreatobiliary cancer was reviewed.

Keywords

References

  1. National Cancer Center (South Korea). Annual Report of Cancer Statistics in Korea in 2012. Goyang: National Cancer Center; 2012. p. 19-161.
  2. Mancuso A, Calabro F, Sternberg CN. Current therapies and advances in the treatment of pancreatic cancer. Crit Rev Oncol Hematol 2006;58:231-41. https://doi.org/10.1016/j.critrevonc.2006.02.004
  3. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996;223:273-9. https://doi.org/10.1097/00000658-199603000-00007
  4. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567-79. https://doi.org/10.1016/S1091-255X(00)80105-5
  5. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363(9414):1049-57. https://doi.org/10.1016/S0140-6736(04)15841-8
  6. Kleeff J, Michalski C, Friess H, Buchler MW. Pancreatic cancer: from bench to 5-year survival. Pancreas 2006;33:111-8. https://doi.org/10.1097/01.mpa.0000229010.62538.f2
  7. Klapman JB, Chang KJ, Lee JG, Nguyen P. Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am J Gastroenterol 2005;100:2658-61. https://doi.org/10.1111/j.1572-0241.2005.00315.x
  8. Puli SR, Bechtold ML, Buxbaum JL, Eloubeidi MA. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: a meta-analysis and systematic review. Pancreas 2013;42:20-6. https://doi.org/10.1097/MPA.0b013e3182546e79
  9. Hunt GC, Faigel DO. Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 2002;55:232-7. https://doi.org/10.1067/mge.2002.121342
  10. Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Gastrointest Endosc Clin N Am 2005;15:497-511. https://doi.org/10.1016/j.giec.2005.03.002
  11. Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994;190:745-51. https://doi.org/10.1148/radiology.190.3.8115622
  12. Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 2006;4:717-25. https://doi.org/10.1016/j.cgh.2006.02.020
  13. Bhutani MS, Koduru P, Joshi V, Saxena P, Suzuki R, Irisawa A, et al. The role of endoscopic ultrasound in pancreatic cancer screening. Endosc Ultrasound 2016;5:8-16. https://doi.org/10.4103/2303-9027.175876
  14. Wang W, Shpaner A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, et al. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. Gastrointest Endosc 2013;78:73-80. https://doi.org/10.1016/j.gie.2013.01.040
  15. Rosch T, Dittler HJ, Strobel K, Meining A, Schusdziarra V, Lorenz R, et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc 2000;52:469-77. https://doi.org/10.1067/mge.2000.106682
  16. Snady H, Bruckner H, Siegel J, Cooperman A, Neff R, Kiefer L. Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors. Gastrointest Endosc 1994;40:326-33. https://doi.org/10.1016/S0016-5107(94)70065-6
  17. Aslanian H, Salem R, Lee J, Andersen D, Robert M, Topazian M. EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates. Am J Gastroenterol 2005;100:1381-5. https://doi.org/10.1111/j.1572-0241.2005.41675.x
  18. Puli SR, Singh S, Hagedorn CH, Reddy J, Olyaee M. Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: a meta-analysis and systematic review. Gastrointest Endosc 2007;65:788-97. https://doi.org/10.1016/j.gie.2006.08.028
  19. Brugge WR, Lee MJ, Kelsey PB, Schapiro RH, Warshaw AL. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc 1996;43:561-7. https://doi.org/10.1016/S0016-5107(96)70191-8
  20. Soriano A, Castells A, Ayuso C, Ayuso JR, de Caralt MT, Gines MA, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004;99:492-501. https://doi.org/10.1111/j.1572-0241.2004.04087.x
  21. Ahmad NA, Lewis JD, Ginsberg GG, Rosato EF, Morris JB, Kochman ML. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000;52:463-8. https://doi.org/10.1067/mge.2000.107725
  22. Ramsay D, Marshall M, Song S, Zimmerman M, Edmunds S, Yusoff I, et al. Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging. Australas Radiol 2004;48:154-61. https://doi.org/10.1111/j.1440-1673.2004.01277.x
  23. Montgomery MM, Leitman IM. Endoscopic ultrasound and paracentesis in the evaluation of small volume ascites in patients with intra-abdominal malignancies. World J Gastroenterol 2014;20(30):10219-22. https://doi.org/10.3748/wjg.v20.i30.10219
  24. Lee YT, Ng EK, Hung LC, Chung SC, Ching JY, Chan WY, et al. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut 2005;54:1541-5. https://doi.org/10.1136/gut.2004.055772
  25. Eloubeidi MA, Jhala D, Chhieng DC, Chen VK, Eltoum I, Vickers S, et al. Yield of endoscopic ultrasound-guided fineneedle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003;99:285-92. https://doi.org/10.1002/cncr.11643
  26. Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 2002;97:1386-91. https://doi.org/10.1111/j.1572-0241.2002.05777.x
  27. Turner BG, Cizginer S, Agarwal D, Yang J, Pitman MB, Brugge WR. Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc 2010;71:91-8. https://doi.org/10.1016/j.gie.2009.06.017
  28. Savides TJ, Donohue M, Hunt G, Al-Haddad M, Aslanian H, Ben-Menachem T, et al. EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: a benchmark for quality performance measurement. Gastrointest Endosc 2007;66:277-82. https://doi.org/10.1016/j.gie.2007.01.017
  29. Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Surg Clin North Am 2010;90:251-63. https://doi.org/10.1016/j.suc.2010.01.002
  30. Katanuma A, Maguchi H, Hashigo S, Kaneko M, Kin T, Yane K, et al. Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy 2012;44(Suppl 2 UCTN):E160-1. https://doi.org/10.1055/s-0031-1291716
  31. Krishna NB, Mehra M, Reddy AV, Agarwal B. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics. Gastrointest Endosc 2009;70:70-9. https://doi.org/10.1016/j.gie.2008.10.030
  32. Eloubeidi MA, Tamhane A. Prospective assessment of diagnostic utility and complications of endoscopic ultrasoundguided fine needle aspiration. Results from a newly developed academic endoscopic ultrasound program. Dig Dis 2008;26:356-63. https://doi.org/10.1159/000177022
  33. Adler DG, Jacobson BC, Davila RE, Hirota WK, Leighton JA, Qureshi WA, et al. ASGE guideline: complications of EUS. Gastrointest Endosc 2005;61:8-12. https://doi.org/10.1016/S0016-5107(04)02393-4
  34. Bader M, Koppenhagen K. Somatostatin receptor scintigraphy in the diagnosis of neuroendocrine gastroenteropancreatic tumors. Recent Results Cancer Res 1996;142:137-62.
  35. Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 1997;38:853-8.
  36. Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000;95:2271-7. https://doi.org/10.1111/j.1572-0241.2000.02480.x
  37. Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004;60:378-84. https://doi.org/10.1016/S0016-5107(04)01807-3
  38. Fritscher-Ravens A. Endoscopic ultrasound and neuroendocrine tumours of the pancreas. JOP 2004;5:273-81.
  39. Allen PJ, D'Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006;244:572-82.
  40. Tada M, Kawabe T, Arizumi M, Togawa O, Matsubara S, Yamamoto N, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol 2006;4:1265-70. https://doi.org/10.1016/j.cgh.2006.07.013
  41. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012;142:796-804. https://doi.org/10.1053/j.gastro.2012.01.005
  42. Lee HJ, Kim MJ, Choi JY, Hong HS, Kim KA. Relative accuracy of CT and MRI in the differentiation of benign from malignant pancreatic cystic lesions. Clin Radiol 2011;66:315-21. https://doi.org/10.1016/j.crad.2010.06.019
  43. Levy MJ. Pancreatic cysts. Gastrointest Endosc 2009;69(2 Suppl):S110-6. https://doi.org/10.1016/j.gie.2008.12.011
  44. Gress F, Gottlieb K, Cummings O, Sherman S, Lehman G. Endoscopic ultrasound characteristics of mucinous cystic neoplasms of the pancreas. Am J Gastroenterol 2000;95:961-5. https://doi.org/10.1111/j.1572-0241.2000.01976.x
  45. Karoumpalis I, Christodoulou DK. Cystic lesions of the pancreas. Ann Gastroenterol 2016;29:155-61.
  46. Chang KJ. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors. Endoscopy 2006;38(Suppl 1):S56-60.
  47. Sand JA, Hyoty MK, Mattila J, Dagorn JC, Nordback IH. Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions in the pancreas. Surgery 1996;119:275-80. https://doi.org/10.1016/S0039-6060(96)80113-9
  48. Genevay M, Mino-Kenudson M, Yaeger K, Konstantinidis IT, Ferrone CR, Thayer S, et al. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg 2011;254:977-83. https://doi.org/10.1097/SLA.0b013e3182383118
  49. Hammel P, Levy P, Voitot H, Levy M, Vilgrain V, Zins M, et al. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology 1995;108:1230-5. https://doi.org/10.1016/0016-5085(95)90224-4
  50. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330-6. https://doi.org/10.1053/j.gastro.2004.02.013
  51. Farley DR, Weaver AL, Nagorney DM. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995;70:425-9. https://doi.org/10.4065/70.5.425
  52. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999;230:663-71. https://doi.org/10.1097/00000658-199911000-00008
  53. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009;33:1247-54. https://doi.org/10.1007/s00268-009-9970-0
  54. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525-31. https://doi.org/10.1046/j.1365-2168.2002.02268.x
  55. Pugliese V, Conio M, Nicolo G, Saccomanno S, Gatteschi B. Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc 1995;42:520-6. https://doi.org/10.1016/S0016-5107(95)70004-8
  56. Pugliese V, Antonelli G, Vincenti M, Gatteschi B. Endoductal tissue sampling of biliary strictures through endoscopic retrograde cholangiopan creatography (ERCP). Tumori 1997;83:698-702. https://doi.org/10.1177/030089169708300314
  57. Fogel EL, deBellis M, McHenry L, Watkins JL, Chappo J, Cramer H, et al. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc 2006;63:71-7. https://doi.org/10.1016/j.gie.2005.08.039
  58. Strongin A, Singh H, Eloubeidi MA, Siddiqui AA. Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound 2013;2:71-6. https://doi.org/10.4103/2303-9027.117690
  59. Schule S, Altendorf-Hofmann A, Utess F, Rauchfuss F, Freesmeyer M, Knosel T, et al. Liver transplantation for hilar cholangiocarcinoma-a single-centre experience. Langenbecks Arch Surg 2013;398:71-7. https://doi.org/10.1007/s00423-012-1007-8
  60. Friman S, Foss A, Isoniemi H, Olausson M, Hockerstedt K, Yamamoto S, et al. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results. Scand J Gastroenterol 2011;46:370-5. https://doi.org/10.3109/00365521.2010.533384
  61. Faige DO. EUS in patients with benign and malignant lymphadenopathy. Gastrointest Endosc 2001;53:593-8. https://doi.org/10.1067/mge.2001.114060
  62. Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997;45:474-9. https://doi.org/10.1016/S0016-5107(97)70176-7
  63. Mohamadnejad M, DeWitt JM, Sherman S, LeBlanc JK, Pitt HA, House MG, et al. Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience. Gastrointest Endosc 2011;73:71-8. https://doi.org/10.1016/j.gie.2010.08.050
  64. Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol 2004;99:45-51. https://doi.org/10.1046/j.1572-0241.2003.04006.x
  65. Eloubeidi MA, Chen VK, Jhala NC, Eltoum IE, Jhala D, Chhieng DC, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2004;2:209-13. https://doi.org/10.1016/S1542-3565(04)00005-9
  66. DeWitt J, Misra VL, Leblanc JK, McHenry L, Sherman S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc 2006;64:325-33. https://doi.org/10.1016/j.gie.2005.11.064
  67. Ohshima Y, Yasuda I, Kawakami H, Kuwatani M, Mukai T, Iwashita T, et al. EUS-FNA for suspected malignant biliary strictures after negative endoscopic transpapillary brush cytology and forceps biopsy. J Gastroenterol 2011;46:921-8. https://doi.org/10.1007/s00535-011-0404-z
  68. Lundstedt C, Stridbeck H, Andersson R, Tranberg KG, Andren-Sandberg A. Tumor seeding occurring after fine-needle biopsy of abdominal malignancies. Acta Radiol 1991;32:518-20. https://doi.org/10.1177/028418519103200615
  69. Heimbach JK, Sanchez W, Rosen CB, Gores GJ. Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford) 2011;13:356-60. https://doi.org/10.1111/j.1477-2574.2011.00298.x